These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 30875336)

  • 21. Understanding Cost-Effectiveness Analyses: An Explanation Using Three Different Analyses of Lung Cancer Screening.
    Curl PK; Kahn JG; Ordovas KG; Elicker BM; Naeger DM
    AJR Am J Roentgenol; 2015 Aug; 205(2):344-7. PubMed ID: 26204285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis.
    Black WC
    J Thorac Imaging; 2015 Mar; 30(2):79-87. PubMed ID: 25635704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of positron emission tomography scanning in the management of lung nodules detected at baseline computed tomography screening.
    Veronesi G; Bellomi M; Veronesi U; Paganelli G; Maisonneuve P; Scanagatta P; Leo F; Pelosi G; Travaini L; Rampinelli C; Trifirò G; Sonzogni A; Spaggiari L
    Ann Thorac Surg; 2007 Sep; 84(3):959-65; discussion 965-6. PubMed ID: 17720408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of the Risk of Malignancy Among Detected Lung Nodules in the National Lung Screening Trial.
    Hassannezhad R; Vahed N
    J Am Coll Radiol; 2018 Nov; 15(11):1529-1535. PubMed ID: 30145120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early detection of lung cancer using ultra-low-dose computed tomography in coronary CT angiography scans among patients with suspected coronary heart disease.
    Zanon M; Pacini GS; de Souza VVS; Marchiori E; Meirelles GSP; Szarf G; Torres FS; Hochhegger B
    Lung Cancer; 2017 Dec; 114():1-5. PubMed ID: 29173759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transbronchial biopsy guided by low-dose MDCT: a new approach for assessment of solitary pulmonary nodules.
    Heyer CM; Kagel T; Lemburg SP; Walter JW; de Zeeuw J; Junker K; Mueller KM; Nicolas V; Bauer TT
    AJR Am J Roentgenol; 2006 Oct; 187(4):933-9. PubMed ID: 16985137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Screening for lung cancer by low-dose computed tomography].
    Gomi S; Nakamura Y; Muramatsu Y
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2005 Jun; 61(6):874-80. PubMed ID: 15995620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.
    Mets OM; Buckens CF; Zanen P; Isgum I; van Ginneken B; Prokop M; Gietema HA; Lammers JW; Vliegenthart R; Oudkerk M; van Klaveren RJ; de Koning HJ; Mali WP; de Jong PA
    JAMA; 2011 Oct; 306(16):1775-81. PubMed ID: 22028353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer.
    Kelly RF; Tran T; Holmstrom A; Murar J; Segurola RJ
    Chest; 2004 Apr; 125(4):1413-23. PubMed ID: 15078754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lung cancer screening with low dose CT requires careful consideration].
    Saghir Z; Dirksen A; Ashraf H; Bach KS; Brodersen J; Clementsen PF; Døssing M; Hansen H; Kofoed KF; Larsen KR; Mortensen J; Rasmussen JF; Thomsen LH; Wille MM; Seersholm N; Skov BG; Thorsen H; Tønnesen P; Pedersen JH
    Ugeskr Laeger; 2014 Oct; 176(42):. PubMed ID: 25316363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of non-small-cell lung cancer from the French healthcare system perspective.
    Alzahouri K; Lejeune C; Woronoff-Lemsi MC; Arveux P; Guillemin F
    Clin Radiol; 2005 Apr; 60(4):479-92. PubMed ID: 15767106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings.
    Gareen IF; Black WC; Tosteson TD; Wang Q; Sicks JD; Tosteson ANA
    Med Care; 2018 May; 56(5):403-409. PubMed ID: 29613874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of a screening programme for lung cancer in former asbestos workers.
    Mastrangelo G; Ballarin MN; Bellini E; Bizzotto R; Zannol F; Gioffrè F; Gobbi M; Tessadri G; Marchiori L; Marangi G; Bozzolan S; Lange JH; Valentini F; Spolaore P
    Occup Med (Lond); 2008 May; 58(3):175-80. PubMed ID: 18346953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Cost-Effectiveness Analysis of Lung Cancer Screening With Low-Dose Computed Tomography and a Diagnostic Biomarker.
    Toumazis I; Erdogan SA; Bastani M; Leung A; Plevritis SK
    JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34738073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation.
    van Loon J; Grutters JP; Wanders R; Boersma L; Dingemans AM; Bootsma G; Geraedts W; Pitz C; Simons J; Brans B; Snoep G; Hochstenbag M; Lambin P; De Ruysscher D
    Eur J Cancer; 2010 Jan; 46(1):110-9. PubMed ID: 19944595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy.
    Gugiatti A; Grimaldi A; Rossetti C; Lucignani G; De Marchis D; Borgonovi E; Fazio F
    Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):49-61. PubMed ID: 15195004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of [(18)F]Fluoro-2-deoxy-d-glucose Positron Emission Tomographic Imaging in the National Lung Screening Trial.
    Nair VS; Sundaram V; Gould MK; Desai M
    Chest; 2016 Sep; 150(3):621-30. PubMed ID: 27179906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening.
    Wisnivesky JP; Mushlin AI; Sicherman N; Henschke C
    Chest; 2003 Aug; 124(2):614-21. PubMed ID: 12907551
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.